Our structural mapping of disease-relevant rasopathy mutations in SHOC2, MRAS and PP1C, as well as structure–function studies on specific SHOC2 GOF and LOF variants, establish a mechanistic basis for their function. This evidence concerns the gene MRAS and RASopathy.